Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in GuillainBarre syndrome and multiple sclerosis patients

International Journal of Neuroscience

Volumn 120, Issue 4, 2010, Pages 301-304

  Ghabaee, Mojdeh ^a   Jabedari, Behnam ^a   Al E Eshagh, Naser ^a   Ghaffarpour, Majid ^a   Asadi, Farzad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Antioxidant activity; Cerebrospinal fluid; GuillainBarre syndrome; Malondialdehyde; Multiple sclerosis; Serum

Indexed keywords

ANTIOXIDANT; LIPID; MALONALDEHYDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; LIPID PEROXIDATION; MALE; MULTIPLE SCLEROSIS; SERUM; SPECTROPHOTOMETRY;

ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MULTIPLE SCLEROSIS;

EID: 77950847084     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207451003695690     Document Type: Article

References (26)

1. Arita, M., Sato, Y., Arai, H., & Inoue, K. (1998). Binding of alphatocopherylquinone, an oxidized form of alpha-tocopherol, to glutathione S-transferase in the liver cytosol. FEBS Letters, 436, 424-426.
2. Asbury, A. K.,&Cornblath,D. R. (1990). Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of Neurology, 27, 21-24.
3. Besler, H. T., & Comoglu, S. (2003). Lipoprotein oxidation, plasma total antioxidant capacity and homocystein level in patients with multiple sclerosis. Nutritional Neuroscience, 6, 189-196.
4. Bourne, N., Wathes, D. C., McGowan, M., & Laven, R. A. (2007). Comparison of the effects of parenteral and oral administration of supplementary vitamin E on plasma vitamin E concentrations in dairy cows at different stages of lactation. Livestock Science, 106, 57-64.
5. Calabrese, V., Raffaele, R., Cosentino, E., & Rizza, V. (1994). Changes in cerebrospinal fluid levels of malondialdehyde and gluthatione reductase activity in multiple sclerosis. International Journal of Clinical Pharmacology Research, 14, 119-123.
6. Carletti, M., Cantiello, M., Giantin, M., Nebbia, C., Cannizo, F. T., Bollo, E., et al. (2007). Serum antioxidant activities and oxidative stress parameters as possible biomarkers of exposure in veal calves illegally treated with dexamethasone. Toxicology in vitro, 21, 277-283.
7. Carter, J. N., Gill, D. R., Krehbiel, C. R., Confer, A.W., Smith, R. A., Lalman,D. L., et al. (2005). Vitamin E supplementation of newly arrived feedlot calves. Journal of Animal Science, 83, 1924-1932.
8. Choi, S. W., Benzie, I. F. F., Collins, A. R., Hannigan, B. M., & Strain, J. J. (2004). Vitamins C and E: Acute interactive effects on biomarkers ofantioxidant defence and oxidative stress. Mutatation Research, 551, 109-117.
9. Dib, M., Garrel, C., Favier, A., Robin, V., & Desnuelle, C. (2002). Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? Journal of Neurology, 249, 367-374.
10. Doba, T., Burton, G. W., & Ingold, K. U. (1985). Antioxidant and antioxidant capacity of vitamin C the effect of vitamin C, either alone or in the presence of vitamin E or water - soluble vitamine E analogue, up on the peroxidation of aqueous multilamellar phospholipids liposomes. Biochimica et Biophysica Acta, 835, 298-303.
11. Ferreti, G., Bacchetti, T., Principi, F., Di Ludovico, F., Viti, B., Angeleri, V., et al. (2005) Increased levels of lipid hydroperoxidase in plasma of patients with multiple sclerosis: A relationship with paroxonase activity. Multiple Sclerosis, 11, 677-682.
12. Frohman, E. M., Racke, M. K., & Raine, C. S. (2006). Multiple sclerosis-the plaque and its pathogenesis. The New England Journal of Medicine, 354, 942-955.
13. Greco, A., Minghetti, L., Puopolo, M., Cannoni, S., Romano, S., Pozzilli, C., et al. (2004). Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences, 224, 23-27.
14. Gutowski,N. J., Pinkham, J. M., AKanmu,D., Chirico, S., & Murphy, R. P. (1998). Free radicals in inflammatory neurological disease: Increased lipid peroxidation and haptoglobin levels in Guillain-Barre syndrome. Irish Journal of Medical Sciences, 167, 43-46.
15. Hunter, M. I., Nlemadim, B. C., & Davidson, D. L. (1985). Lipid peroxidation products and antioxidants proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochemical Research, 10, 1645-1652.
16. Karg, E., Klivenyi, P., Nemeth, I., Bencsik, K., Pinter, S., & Vecsei, L. (2004). Nonenzymatic antioxidants of blood in multiple sclerosi. Journal of Neurology, 246, 1432-1459.
17. Kaur, C., & Ling, E. A. (2008). Antioxidant and neuroprotection in the adult and developing central nervous system. Current Medicinal Chemistry, 15, 3068-3080.
18. Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S., & Cosic, V. (2001). Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54, 356-361.
19. Kumar, K. T., Vhandrika, A., Sumanth, K. N., Sireesh, P., Roa, S., & Roa, A. (2004). Free radical toxicity and antioxidants inGuillain-Barre syndrome a preliminary study. Clinica Chimica Acta, 364, 205-209.
20. Ledwózyw, A., Michalak, J., St̃epie ́ n, A. K., & Áadziolka, A. (1986). The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human. Atherosclerosis. Clinica Chimica Acta, 155, 275-284.
21. McDonald,W. I. (2001). Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121-127.
22. Nazlie, B., Taskiran, D., Irkec, C., Kutay, F. Z., & Pogun, S. (2002). Serumnitric oxide metabolites in patients with multiple sclerosis. Journal of Clinical Neuroscience, 9, 530-532.
23. Nussinovitch, M., Volovitz, B., Finkelstein, Y., Amir, J., & Harel, D. (2001). Lactic dehydrogenase isoenzymes in cerebrospinal fluid associated with hydrocephalus. Acta Paediatrica, 90, 972-974.
24. Peresedova, A. V., Baidina, E. V., Trifonova, O. V., Korepina, O. S., Gnezditskii, V. V., Krotenkova, M. V., et al. (2009). Pathophysiologyical aspects of the formation of neurological deficit in Multiple Sclerosis. Neuroscience and Behavioral Physiology, 39, 39-45.
25. Sakai, T., Inoue, A., Koh, C. S., & Ikeda, S. (2000). A study of free radical defense and oxidative stress in the sera of patients with neuroimmunological disorders. Arerugi, 49, 12-18.
26. Silverman, L. M., & Christenson, R. H. (1995). Amino acids and proteins. In C. A. Burtis and E. R. Ashwood (eds.), Tietz Textbook of Clinical Chemistry. Philadelphia: W.B. Saunders Company, 625-671.